Perhexiline: Old Drug, New Tricks? A Summary of Its Anti-Cancer Effects
Cancer metabolic plasticity, including changes in fatty acid metabolism utilisation, is now widely appreciated as a key driver for cancer cell growth, survival and malignancy. Hence, cancer metabolic pathways have been the focus of much recent drug development. Perhexiline is a prophylactic antiangi...
Main Authors: | Bimala Dhakal, Yoko Tomita, Paul Drew, Timothy Price, Guy Maddern, Eric Smith, Kevin Fenix |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/28/8/3624 |
Similar Items
-
The Antianginal Drug Perhexiline Displays Cytotoxicity against Colorectal Cancer Cells In Vitro: A Potential for Drug Repurposing
by: Bimala Dhakal, et al.
Published: (2022-02-01) -
Proteomic characterisation of perhexiline treatment on THP-1 M1 macrophage differentiation
by: Bimala Dhakal, et al.
Published: (2023-03-01) -
Perhexiline Therapy in Patients with Type 2 Diabetes: Incremental Insulin Resistance despite Potentiation of Nitric Oxide Signaling
by: Cher-Rin Chong, et al.
Published: (2022-09-01) -
Bacterial Outer Membrane Vesicles Loaded with Perhexiline Suppress Tumor Development by Regulating Tumor-Associated Macrophages Repolarization in a Synergistic Way
by: Shoujin Jiang, et al.
Published: (2023-07-01) -
Targeting one-carbon metabolism requires mTOR inhibition: a new therapeutic approach in osteosarcoma
by: Richa Rathore, et al.
Published: (2021-05-01)